CAV1 and neoplasm: Patients who had tumours that were positive for both caveolin-1 and pAKT had significantly worse prognosis than patients who had tumours that expressed neither biomarker or either caveolin-1 or pAKT alone, with a mean disease-free survival of 2.95 vs 6.14 years (P<0.0001).